310 related articles for article (PubMed ID: 32798665)
21. Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo.
Navarro G; Tros de Ilarduya C
Nanomedicine; 2009 Sep; 5(3):287-97. PubMed ID: 19523431
[TBL] [Abstract][Full Text] [Related]
22. Effects of PEGylation and acetylation of PAMAM dendrimers on DNA binding, cytotoxicity and in vitro transfection efficiency.
Fant K; Esbjörner EK; Jenkins A; Grossel MC; Lincoln P; Nordén B
Mol Pharm; 2010 Oct; 7(5):1734-46. PubMed ID: 20695423
[TBL] [Abstract][Full Text] [Related]
23. Molecular modeling and in vivo imaging can identify successful flexible triazine dendrimer-based siRNA delivery systems.
Merkel OM; Zheng M; Mintzer MA; Pavan GM; Librizzi D; Maly M; Höffken H; Danani A; Simanek EE; Kissel T
J Control Release; 2011 Jul; 153(1):23-33. PubMed ID: 21342661
[TBL] [Abstract][Full Text] [Related]
24. Recent Advances in Preclinical Research Using PAMAM Dendrimers for Cancer Gene Therapy.
Tarach P; Janaszewska A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805602
[TBL] [Abstract][Full Text] [Related]
25. Ruthenium dendrimers as carriers for anticancer siRNA.
Michlewska S; Ionov M; Maroto-Díaz M; Szwed A; Ihnatsyeu-Kachan A; Loznikova S; Shcharbin D; Maly M; Ramirez RG; de la Mata FJ; Bryszewska M
J Inorg Biochem; 2018 Apr; 181():18-27. PubMed ID: 29353086
[TBL] [Abstract][Full Text] [Related]
26. Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery.
Biswas S; Deshpande PP; Navarro G; Dodwadkar NS; Torchilin VP
Biomaterials; 2013 Jan; 34(4):1289-301. PubMed ID: 23137395
[TBL] [Abstract][Full Text] [Related]
27. Anti-inflammatory and anti-oxidant activity of anionic dendrimer-N-acetyl cysteine conjugates in activated microglial cells.
Wang B; Navath RS; Romero R; Kannan S; Kannan R
Int J Pharm; 2009 Jul; 377(1-2):159-68. PubMed ID: 19463931
[TBL] [Abstract][Full Text] [Related]
28. gamma-Glutamyl PAMAM dendrimer as versatile precursor for dendrimer-based targeting devices.
Uehara T; Ishii D; Uemura T; Suzuki H; Kanei T; Takagi K; Takama M; Murakami M; Akizawa H; Arano Y
Bioconjug Chem; 2010 Jan; 21(1):175-81. PubMed ID: 20000792
[TBL] [Abstract][Full Text] [Related]
29. Lipodendriplexes: A promising nanocarrier for enhanced gene delivery with minimal cytotoxicity.
Tariq I; Pinnapireddy SR; Duse L; Ali MY; Ali S; Amin MU; Goergen N; Jedelská J; Schäfer J; Bakowsky U
Eur J Pharm Biopharm; 2019 Feb; 135():72-82. PubMed ID: 30590107
[TBL] [Abstract][Full Text] [Related]
30. Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain.
Kim ID; Lim CM; Kim JB; Nam HY; Nam K; Kim SW; Park JS; Lee JK
J Control Release; 2010 Mar; 142(3):422-30. PubMed ID: 19944723
[TBL] [Abstract][Full Text] [Related]
31. Modulating circulating sFlt1 in an animal model of preeclampsia using PAMAM nanoparticles for siRNA delivery.
Yu J; Jia J; Guo X; Chen R; Feng L
Placenta; 2017 Oct; 58():1-8. PubMed ID: 28962687
[TBL] [Abstract][Full Text] [Related]
32. Comparative anti-inflammatory activity of poly(amidoamine) (PAMAM) dendrimer-dexamethasone conjugates with dexamethasone-liposomes.
Choksi A; Sarojini KV; Vadnal P; Dias C; Suresh PK; Khandare J
Int J Pharm; 2013 Jun; 449(1-2):28-36. PubMed ID: 23583708
[TBL] [Abstract][Full Text] [Related]
33. PAMAM-cRGD mediating efficient siRNA delivery to spermatogonial stem cells.
Li T; Chen Q; Zheng Y; Zhang P; Chen X; Lu J; Lv Y; Sun S; Zeng W
Stem Cell Res Ther; 2019 Dec; 10(1):399. PubMed ID: 31852526
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary RNA interference against acute lung injury mediated by mucus- and cell-penetrating nanocomplexes.
Zhang W; Shen J; Liang J; Ge C; Zhou Y; Yin L; Ji Y
Acta Biomater; 2024 Mar; 177():332-346. PubMed ID: 38290689
[TBL] [Abstract][Full Text] [Related]
35. Visualizing the attack of RNase enzymes on dendriplexes and naked RNA using atomic force microscopy.
Abdelhady HG; Lin YL; Sun H; ElSayed ME
PLoS One; 2013; 8(4):e61710. PubMed ID: 23637890
[TBL] [Abstract][Full Text] [Related]
36. PAMAM Dendrimers as a Delivery System for Small Interfering RNA.
Kheiriabad S; Ghaffari M; Dolatabadi JEN; Hamblin MR
Methods Mol Biol; 2020; 2115():91-106. PubMed ID: 32006396
[TBL] [Abstract][Full Text] [Related]
37. Charge reversible hyaluronic acid-modified dendrimer-based nanoparticles for siMDR-1 and doxorubicin co-delivery.
Zhang X; Pan J; Yao M; Palmerston Mendes L; Sarisozen C; Mao S; Torchilin VP
Eur J Pharm Biopharm; 2020 Sep; 154():43-49. PubMed ID: 32645383
[TBL] [Abstract][Full Text] [Related]
38. Anticancer siRNA cocktails as a novel tool to treat cancer cells. Part (A). Mechanisms of interaction.
Ionov M; Lazniewska J; Dzmitruk V; Halets I; Loznikova S; Novopashina D; Apartsin E; Krasheninina O; Venyaminova A; Milowska K; Nowacka O; Gomez-Ramirez R; de la Mata FJ; Majoral JP; Shcharbin D; Bryszewska M
Int J Pharm; 2015 May; 485(1-2):261-9. PubMed ID: 25791760
[TBL] [Abstract][Full Text] [Related]
39. Role of generation, architecture, pH and ionic strength on successful siRNA delivery and transfection by hybrid PPV-PAMAM dendrimers.
Pavan GM; Monteagudo S; Guerra J; Carrión B; Ocaña V; Rodríguez-Lopez J; Danani A; Pérez-Martínez FC; Ceña V
Curr Med Chem; 2012; 19(29):4929-41. PubMed ID: 22963640
[TBL] [Abstract][Full Text] [Related]
40. In vivo delivery of siRNA to the brain by carbosilane dendrimer.
Serramía MJ; Álvarez S; Fuentes-Paniagua E; Clemente MI; Sánchez-Nieves J; Gómez R; de la Mata J; Muñoz-Fernández MÁ
J Control Release; 2015 Feb; 200():60-70. PubMed ID: 25559178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
